Key Information

You have come to the Abstract Submission and Guidelines page for Summit4CI taking place Nov. 7-9, 2020, in Montréal Quebec. Please note, more details will be coming soon.

Abstract Submission Deadline & Other Key Dates

All key dates relating to Abstracts can be found on the Key Dates and Deadlines 2020 Summit4CI page. All deadlines are at 11:59 PM Pacific Time.

HQP Travel Award and Eligibility

BioCanRx will be providing travel support for up to 100 HQP to a maximum amount of $1200* to attend Summit4CI. Highly qualified personnel (HQP) are defined as undergraduates, graduate students, post-doctoral fellows and other positions integral for the translation of cancer biotherapeutics working in an academic setting. Individuals working in positions at the professorial level eligible to receive CIHR funding as a lead investigator are ineligible to receive HQP Travel Awards. Travel awards will be adjudicated based on the quality of abstracts. The authors of the top-ranked abstracts will be invited to present an oral presentation during the oral plenary or speed poster presentation. Other awardees will be presenting during the poster sessions.

Adjudication of HQP travel awards and notification to applicants will be one (1) week prior to early bird registration closing.

*This amount will be dependent on geographic location of HQP

IMPORTANT INFORMATION REGARDING POSTER PRESENTATIONS:

Please note that the number of poster spots is limited.

Poster spots will only be reserved for abstracts that are submitted before the abstract submission deadline of June 8, 2020, and are selected for a poster presentation by the Summit4CI Abstract Review Board. Award of all poster spots will be determined by the Summit4CI Abstract Review Board and are subject to availability of space.